Follow
Peter Willeit
Peter Willeit
Medical University of Innsbruck and University of Cambridge
Verified email at cam.ac.uk - Homepage
Title
Cited by
Cited by
Year
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128ˇ 9 million …
L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ...
The lancet 390 (10113), 2627-2642, 2017
80162017
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19ˇ 1 million participants
B Zhou, J Bentham, M Di Cesare, H Bixby, G Danaei, MJ Cowan, ...
The Lancet 389 (10064), 37-55, 2017
27432017
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
E Di Angelantonio, SN Bhupathiraju, D Wormser, P Gao, S Kaptoge, ...
The Lancet 388 (10046), 776-786, 2016
27182016
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 …
B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ...
The Lancet 398 (10304), 957-980, 2021
20972021
Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes
A Zampetaki, S Kiechl, I Drozdov, P Willeit, U Mayr, M Prokopi, A Mayr, ...
Circulation research 107 (6), 810-817, 2010
17042010
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
AM Wood, S Kaptoge, AS Butterworth, P Willeit, S Warnakula, T Bolton, ...
The Lancet 391 (10129), 1513-1523, 2018
11892018
Cardioprotection and lifespan extension by the natural polyamine spermidine
T Eisenberg, M Abdellatif, S Schroeder, U Primessnig, S Stekovic, T Pendl, ...
Nature medicine 22 (12), 1428-1438, 2016
9612016
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
IL6R Genetics Consortium Emerging Risk Factors Collaboration
The Lancet 379 (9822), 1205-1213, 2012
8962012
Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis
PC Haycock, EE Heydon, S Kaptoge, AS Butterworth, A Thompson, ...
Bmj 349, 2014
8952014
Association of cardiometabolic multimorbidity with mortality
E Di Angelantonio, S Kaptoge, D Wormser, P Willeit, AS Butterworth, ...
Jama 314 (1), 52-60, 2015
8602015
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
S Kaptoge, L Pennells, D De Bacquer, MT Cooney, M Kavousi, G Stevens, ...
The Lancet global health 7 (10), e1332-e1345, 2019
8482019
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge
R Saxena, MF Hivert, C Langenberg, T Tanaka, JS Pankow, ...
Nature genetics 42 (2), 142-148, 2010
7502010
Rising rural body-mass index is the main driver of the global obesity epidemic in adults
Nature 569 (7755), 260-264, 2019
7372019
Lipid-related markers and cardiovascular disease prediction
R Used
Jama 307 (2499), 506, 2012
6072012
Telomere length and risk of incident cancer and cancer mortality
P Willeit, J Willeit, A Mayr, S Weger, F Oberhollenzer, A Brandstätter, ...
Jama 304 (1), 69-75, 2010
5542010
Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study
C Stegemann, R Pechlaner, P Willeit, SR Langley, M Mangino, U Mayr, ...
Circulation 129 (18), 1821-1831, 2014
5442014
Prospective study on circulating MicroRNAs and risk of myocardial infarction
A Zampetaki, P Willeit, L Tilling, I Drozdov, M Prokopi, JM Renard, A Mayr, ...
Journal of the American College of Cardiology 60 (4), 290-299, 2012
5302012
Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study
PC Haycock, S Burgess, A Nounu, J Zheng, GN Okoli, J Bowden, ...
JAMA oncology 3 (5), 636-651, 2017
4942017
Association of LPA variants with risk of coronary disease and the implications for lipoprotein (a)-lowering therapies: a Mendelian randomization analysis
S Burgess, BA Ference, JR Staley, DF Freitag, AM Mason, SF Nielsen, ...
JAMA cardiology 3 (7), 619-627, 2018
4862018
Baseline and on-statin treatment lipoprotein (a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
P Willeit, PM Ridker, PJ Nestel, J Simes, AM Tonkin, TR Pedersen, ...
The Lancet 392 (10155), 1311-1320, 2018
4782018
The system can't perform the operation now. Try again later.
Articles 1–20